December 24, 2024 - 17:32

SEALSQ Corp is making significant strides in the field of Post-Quantum Cryptography (PQC) with its innovative QUASARS project. This initiative aims to address potential vulnerabilities that Bitcoin and other cryptocurrencies may face in a future dominated by quantum computing. As quantum technology continues to evolve, the risk of traditional cryptographic methods being compromised grows, prompting the need for robust solutions.
The QUASARS project focuses on developing hybrid solutions that integrate both classical and quantum-resistant cryptographic techniques. By doing so, SEALSQ is not only enhancing the security of digital currencies but also paving the way for a more secure digital future. The incorporation of quantum-resistant hardware is a crucial aspect of this initiative, ensuring that the infrastructure supporting cryptocurrencies can withstand the threats posed by quantum advancements.
As the cryptocurrency landscape evolves, the importance of safeguarding these digital assets cannot be overstated. SEALSQ's commitment to pioneering quantum-resistant technology is a proactive step towards ensuring the integrity and security of Bitcoin and other cryptocurrencies in the face of emerging quantum threats.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...